NuvoAir Company
NuvoAir is a leading digital health company for chronic disease management and decentralized clinical trials. The NuvoAir Home platform blends connected devices with high-touch care coordination services to enable patients and their providers to proactively manage chronic conditions, resulting in better outcomes and lower costs. NuvoAir Home currently supports thousands of patients worldwide with COPD, cystic fibrosis, severe asthma, IPF, ALS, and muscular dystrophy. NuvoAir's decentralized clinical trial solution has been used in over 30 studies globally across all phases of drug development.
Founded Date:
2016-01-01
Total Funding:
17160100
Employee Number:
11-50
Funding Status:
Early Stage Venture
Technology:
P4 Medicine
Last Funding Type:
Series A
Investors Number:
8
Industry:
P4 Medicine
Headquarters:
Boston, Massachusetts, United States
Estimated Revenue:
Less than $1M